Drug General Information |
Drug ID |
D0L4QC
|
Former ID |
DNC012379
|
Drug Name |
3-Hydroxy-6-methyl-1H-benzo[b]azepine-2,5-dione
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C11H9NO3
|
Canonical SMILES |
CC1=C2C(=CC=C1)NC(=O)C(=O)C=C2O
|
InChI |
1S/C11H9NO3/c1-6-3-2-4-7-10(6)8(13)5-9(14)11(15)12-7/h2-5,13H,1H3,(H,12,14,15)
|
InChIKey |
SFRUZUUPMLUZHX-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Glutamate [NMDA] receptor subunit epsilon 1 |
Target Info |
Inhibitor |
[1]
|
Glutamate [NMDA] receptor subunit epsilon 2 |
Target Info |
Inhibitor |
[1]
|
NMDA receptor subunit NR1 |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Ras signaling pathway
|
Rap1 signaling pathway
|
Calcium signaling pathway
|
cAMP signaling pathway
|
Neuroactive ligand-receptor interaction
|
Circadian entrainment
|
Long-term potentiation
|
Glutamatergic synapse
|
Dopaminergic synapse
|
Alzheimer's disease
|
Amyotrophic lateral sclerosis (ALS)
|
Cocaine addiction
|
Amphetamine addiction
|
Nicotine addiction
|
Alcoholism
|
Systemic lupus erythematosushsa04014:Ras signaling pathway
|
Huntington's disease
|
PANTHER Pathway
|
Huntington disease
|
Ionotropic glutamate receptor pathway
|
Metabotropic glutamate receptor group III pathway
|
Metabotropic glutamate receptor group I pathway
|
Muscarinic acetylcholine receptor 1 and 3 signaling pathwayP00029:Huntington disease
|
Muscarinic acetylcholine receptor 1 and 3 signaling pathway
|
Pathway Interaction Database
|
Reelin signaling pathwayerbb4_pathway:ErbB4 signaling events
|
Reelin signaling pathway
|
Reactome
|
Unblocking of NMDA receptor, glutamate binding and activation
|
CREB phosphorylation through the activation of CaMKII
|
Ras activation uopn Ca2+ infux through NMDA receptor
|
RAF/MAP kinase cascadeR-HSA-3928662:EPHB-mediated forward signaling
|
RAF/MAP kinase cascade
|
WikiPathways
|
Hypothetical Network for Drug Addiction
|
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
|
Alzheimers DiseaseWP666:Hypothetical Network for Drug Addiction
|
BDNF signaling pathwayWP706:SIDS Susceptibility Pathways
|
Spinal Cord Injury
|
BDNF signaling pathway
|
Alzheimers Disease
|
References |
REF 1 | J Med Chem. 1996 Nov 8;39(23):4643-53.Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites. |